The obligation for medical practitioners to report Lyme disease has been introduced in almost half of the federal states of Germany. This means that every medical practitioner that works in those federal states is obliged to report, for example, a “wandering flush” (Erythema migrans, EM, Erythema chronicum migrans, EcM) and/or increased Borrelia IgG antibody titre, as a clinical symptom of Lyme disease to the relevant health authorities. This is considered a positive development in the fight against Lyme disease.
The procedure and forms used to report Lyme disease are not consistent throughout Germany’s federal states and it is often not clear as to whether the doctor or the laboratory team have the duty to report. Unfortunately, the reported cases do not reflect how many cases are actually occurring and there is still the question of whether those cases that get reported correspond to the case definition of the Reporting Office. It is easiest to report erythema migrans (EM) and lymphocytoma – but only if the doctor recognises it.
IMPORTANT: NOT ALL INFECTIONS WITH BORRELIA (OR OTHER TICK-BORNE PATHOGENS SUCH AS BABESIA, ETC.) DEVELOP AN ERYTHEMA MIGRANS OR LYMPHOCYTOMA AFTER THE TICK BITE!
Of course, the Reporting Office can only record and present cases that actually get are reported. The question for the medical community is: Do we recognise all cases and variations of erythema migrans, lymphocytoma and ACA?
Reporting form for Lyme borreliosis
In accordance with the Ordinance of 23 January 2013 on the Extension of the Reporting Obligation to Other Communicable Diseases or Pathogens Download